McWherter Charles - Insider Transactions
Insider Type
individual
Companies
2
Average
355,410
Total Txns
11
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2023 | 0 | 3 | -3 | 0.00 | 450,734.31 | -450,734.31 |
| 2024 | 1 | 5 | -4 | 80,000.00 | 435,644.79 | -355,644.79 |
| 2025 | 2 | 0 | 2 | 99,850.00 | 0.00 | 99,850.00 |
| Total: | 3 | 8 | 10 | 179,850.00 | 886,379.10 | -706,529.10 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| 89bio, Inc. Common Stock US2825591033 |
6.55 USD |
5,000 Bought |
32,750 USD |
21/01/2025 | 21/01/2025 |
| 89bio, Inc. Common Stock US2825591033 |
6.71 USD |
10,000 Bought |
67,100 USD |
21/01/2025 | 22/01/2025 |
| 89bio, Inc. Common Stock US2825591033 |
8.00 USD |
10,000 Bought |
80,000 USD |
05/12/2024 | 05/12/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
23.67 USD |
2,250 Sold |
53,262 USD |
19/01/2024 | 19/01/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
23.66 USD |
2,778 Sold |
65,739 USD |
19/01/2024 | 19/01/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
23.68 USD |
3,125 Sold |
73,988 USD |
19/01/2024 | 19/01/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
23.66 USD |
1,916 Sold |
45,340 USD |
19/01/2024 | 19/01/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
23.68 USD |
8,334 Sold |
197,316 USD |
19/01/2024 | 19/01/2024 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
21.49 USD |
4,828 Sold |
103,738 USD |
18/12/2023 | 18/12/2023 |
| CymaBay Therapeutics Inc. Common Stock US23257D1037 |
21.48 USD |
6,504 Sold |
139,703 USD |
18/12/2023 | 18/12/2023 |